Latest Breaking News On - Cells toward enhanced efficacy - Page 1 : comparemela.com

In this article, Sino Biological demonstrates how Chimeric Antigen Receptors (CARs) can be utilized in novel cancer therapies, a change from the usual application of CARs, which heavily feature T-cells.

South koreaAlex smithSilva santurioSino biological incBiomarker researchSino biological inc aprDrug administrationSponsored contentNatural killerChimeric antigen receptorNovel therapeutic cell typeCancer immune cellOut likeCells toward enhanced efficacySystematic reviewReviews cancer